We have shown that abiraterone, one of the most commonly prescribed drugs for CRPC, induces a significant upregulation of SLCO1B3 transcripts in 22Rv1 and VCaP cells and in mice bearing 22Rv1 tumor xenografts. The gene discussed is SLCO1B3; the disease is neoplasm.